A double-blind controlled evaluation of diprosone cream 0.05% in comparison with synalar cream 0.01% in the treatment of psoriasis and other steroid responsive dermatoses.
D001623:Betamethasone / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005446:Fluocinolone Acetonide / Q000627:therapeutic use*; D006801:Humans; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*
D009824:Ointments; D005446:Fluocinolone Acetonide; D001623:Betamethasone